Vimarsana
Biggest News Aggregation in the World

Suzanne Ildstad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Suzanne Ildstad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Suzanne Ildstad Today - Breaking & Trending Today

Biotech company hopes to make Louisville a hub for cell therapy - Vimarsana News

Biotech company hopes to make Louisville a hub for cell therapy

The former Talaris space on the U of L Health Sciences Campus downtown won't be quiet for long.

Source: wdrb.com
Talaris Therapeutics, Inc. (NASDAQ:TALS) Sees Large Decline in Short Interest - Vimarsana News

Talaris Therapeutics, Inc. (NASDAQ:TALS) Sees Large Decline in Short Interest

Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 270,300 shares, a decrease of 71.7% from the June 15th total of 955,200 shares. Based on an average daily volume of 629,200 shares, […]

Biotech company with Louisville ties to live on through merger - Vimarsana News

Biotech company with Louisville ties to live on through merger

The announcement follows Talaris Therapeutics’ unsuccessful effort to commercialize a stem cell therapy that promised to improve transplant recipients’ tolerance of new organs.

Source: wdrb.com
Talaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells $43,693.30 in Stock - Vimarsana News

Talaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells $43,693.30 in Stock

Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 16,870 shares of the company’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $2.59, for a total value of $43,693.30. Following the transaction, the director now directly owns 3,798,542 shares of the company’s stock, valued […]

Insider Selling: Talaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells $32,225.58 in Stock - Vimarsana News

Insider Selling: Talaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells $32,225.58 in Stock

Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 12,942 shares of Talaris Therapeutics stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $2.49, for a total value of $32,225.58. Following the completion of the transaction, the director now directly owns 3,771,392 shares in the […]